403 related articles for article (PubMed ID: 27017237)
1. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
2. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
[TBL] [Abstract][Full Text] [Related]
3. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
[TBL] [Abstract][Full Text] [Related]
4. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
Onal C; Guler OC; Yildirim BA
Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
[TBL] [Abstract][Full Text] [Related]
6. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
[TBL] [Abstract][Full Text] [Related]
9. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.
Scorsetti M; Clerici E; Navarria P; D'Agostino G; Piergallini L; De Rose F; Ascolese A; Tozzi A; Iftode C; Villa E; Comito T; Franzese C; Mancosu P; Tomatis S; Cozzi L
Br J Radiol; 2015 Sep; 88(1053):20150111. PubMed ID: 26183933
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience.
Alsuhaibani A; Elashwah A; Alkafi A; Constantinescus C; ALzorkany F
J Gastrointest Cancer; 2019 Dec; 50(4):879-887. PubMed ID: 30291546
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.
Milano MT; Zhang H; Metcalfe SK; Muhs AG; Okunieff P
Breast Cancer Res Treat; 2009 Jun; 115(3):601-8. PubMed ID: 18719992
[TBL] [Abstract][Full Text] [Related]
13. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
[TBL] [Abstract][Full Text] [Related]
15. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M
BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798
[TBL] [Abstract][Full Text] [Related]
17. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
18. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
20. Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma.
Franceschini D; Franzese C; De Rose F; Navarria P; D'Agostino GR; Comito T; Tozzi A; Tronconi MC; Di Guardo L; Del Vecchio M; Scorsetti M
Br J Radiol; 2017 Aug; 90(1077):20170257. PubMed ID: 28707533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
